JENKEM TECH CO LTD TIANJIN has a total of 25 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and organic fine chemistry are POLYACTIVA PTY LTD, PHARMASYNTEZ and NANOCARRIER CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Organic fine chemistry | |
#4 | Medical technology | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Zhao Xuan | 24 |
#2 | Feng Zewang | 17 |
#3 | Wang Jinliang | 13 |
#4 | Lin Meina | 9 |
#5 | Xiong Yanli | 6 |
#6 | Liu Yan | 4 |
#7 | Wang Zhen'Guo | 4 |
#8 | Wang Leimin | 4 |
#9 | Zhu Hui | 3 |
#10 | Chen Xiaomeng | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019184993A1 | Combination of polyethylene glycol and rapamycin and use thereof | |
WO2019062665A1 | Linker compound, polyethylene glycol-linker conjugate and derivative thereof, and polyethylene glycol-linker-drug conjugate | |
US2018021442A1 | Low molecular weight polyethylene glycol drug conjugates having improved drug biological activity | |
US2017119736A1 | Compound having higher inhibitory activity on protein kinase G and preparation method thereof | |
EP3078699A1 | Multi-arm polyethylene glycol-nitrine derivative |